These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16618109)

  • 1. Characterization of human saposins by NMR spectroscopy.
    John M; Wendeler M; Heller M; Sandhoff K; Kessler H
    Biochemistry; 2006 Apr; 45(16):5206-16. PubMed ID: 16618109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero)phosphate-rich membranes at acidic pH. Unglycosylated patient variant saposin B lacks lipid-extraction capacity.
    Remmel N; Locatelli-Hoops S; Breiden B; Schwarzmann G; Sandhoff K
    FEBS J; 2007 Jul; 274(13):3405-20. PubMed ID: 17561962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of human saposin C: pH-dependent interaction with phospholipid vesicles.
    de Alba E; Weiler S; Tjandra N
    Biochemistry; 2003 Dec; 42(50):14729-40. PubMed ID: 14674747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of the postulated intramolecular sphingolipid activator protein domain of human acid sphingomyelinase.
    Kölzer M; Ferlinz K; Bartelsen O; Hoops SL; Lang F; Sandhoff K
    Biol Chem; 2004 Dec; 385(12):1193-5. PubMed ID: 15653433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of human saposin C in a detergent environment.
    Hawkins CA; de Alba E; Tjandra N
    J Mol Biol; 2005 Mar; 346(5):1381-92. PubMed ID: 15713488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse testicular sulfated glycoprotein-1: sequence analysis of the common backbone structure of prosaposins.
    Zhao Q; Bell AW; El-Alfy M; Morales CR
    J Androl; 1998; 19(2):165-74. PubMed ID: 9570739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of human saposins C andD: implications for lipid recognition and membrane interactions.
    Rossmann M; Schultz-Heienbrok R; Behlke J; Remmel N; Alings C; Sandhoff K; Saenger W; Maier T
    Structure; 2008 May; 16(5):809-17. PubMed ID: 18462685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of recombinant human saposin A expressed by Pichia pastoris.
    Yamada M; Inui K; Hamada D; Nakahira K; Yanagihara K; Sakai N; Nishigaki T; Ozono K; Yanagihara I
    Biochem Biophys Res Commun; 2004 May; 318(2):588-93. PubMed ID: 15120640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
    Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
    Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural changes in a binary mixed phospholipid bilayer of DOPG and DOPS upon saposin C interaction at acidic pH utilizing 31P and 2H solid-state NMR spectroscopy.
    Abu-Baker S; Qi X; Newstadt J; Lorigan GA
    Biochim Biophys Acta; 2005 Nov; 1717(1):58-66. PubMed ID: 16289479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of saposin D with membranes: effect of anionic phospholipids and sphingolipids.
    Ciaffoni F; Tatti M; Salvioli R; Vaccaro AM
    Biochem J; 2003 Aug; 373(Pt 3):785-92. PubMed ID: 12733985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct visualization of saposin remodelling of lipid bilayers.
    Alattia JR; Shaw JE; Yip CM; Privé GG
    J Mol Biol; 2006 Oct; 362(5):943-53. PubMed ID: 16949605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of the human ceramide activator protein saposin D.
    Popovic K; Privé GG
    Acta Crystallogr D Biol Crystallogr; 2008 May; 64(Pt 5):589-94. PubMed ID: 18453694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The saposin-like proteins 1, 2, and 3 of Fasciola gigantica.
    Grams R; Adisakwattana P; Ritthisunthorn N; Eursitthichai V; Vichasri-Grams S; Viyanant V
    Mol Biochem Parasitol; 2006 Aug; 148(2):133-43. PubMed ID: 16626816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
    Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
    Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid sphingomyelinase possesses a domain homologous to its activator proteins: saposins B and D.
    Ponting CP
    Protein Sci; 1994 Feb; 3(2):359-61. PubMed ID: 8003971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of saposins A and C.
    Ahn VE; Leyko P; Alattia JR; Chen L; Privé GG
    Protein Sci; 2006 Aug; 15(8):1849-57. PubMed ID: 16823039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the interaction of saposin C with POPS and POPC phospholipids: a solid-state NMR spectroscopic study.
    Abu-Baker S; Qi X; Lorigan GA
    Biophys J; 2007 Nov; 93(10):3480-90. PubMed ID: 17704143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide.
    Vaccaro AM; Tatti M; Ciaffoni F; Salvioli R; Barca A; Scerch C
    J Biol Chem; 1997 Jul; 272(27):16862-7. PubMed ID: 9201993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity.
    Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R
    Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.